Details
Stereochemistry | ACHIRAL |
Molecular Formula | Fe.2O4S.2H4N |
Molecular Weight | 284.047 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[NH4+].[NH4+].[Fe++].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=IMBKASBLAKCLEM-UHFFFAOYSA-L
InChI=1S/Fe.2H3N.2H2O4S/c;;;2*1-5(2,3)4/h;2*1H3;2*(H2,1,2,3,4)/q+2;;;;/p-2
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H3N |
Molecular Weight | 17.0305 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
Sources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
Curative | RADIOGARDASE Approved UseInsoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date2003 |
|||
PubMed
Title | Date | PubMed |
---|---|---|
THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA. | 1937 Jul |
|
Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows. | 2013 Jul |
|
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
Sample Use Guides
Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:21:14 GMT 2025
by
admin
on
Mon Mar 31 20:21:14 GMT 2025
|
Record UNII |
9Q764AYJ9G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
||
|
EPA PESTICIDE CODE |
50506
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
24863
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
10045-89-3
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
76243
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
17784
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | RxNorm | ||
|
AMMONIUM IRON(II) SULFATE
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
76181
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
SUB74830
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
100000136584
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
233-151-8
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
C038178
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
456
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
DTXSID4041028
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | |||
|
m1788
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
9Q764AYJ9G
Created by
admin on Mon Mar 31 20:21:14 GMT 2025 , Edited by admin on Mon Mar 31 20:21:14 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |